Lexeo Therapeutics, Inc.
LXEO
DELAYED 1 MONTH

5 insider filings · Latest: May 18, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 18, 2026May 20 8:30 PMJose Manuel OteroChief Operating Officer
Sale
1,302$5.07$6.6K130,088(D)

View →

May 18, 2026May 20 8:30 PMRichard Nolan TownsendDirector, Chief Executive Officer
Sale
3,342$5.06$16.9K336,764(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 28, 2026Apr 30 8:01 PMLaura Sepp-LorenzinoDirector
Grant/Award
50,000$5.8150,000(D)

View →